HPV vaccination: clearance of vaccine-targeted strains and cross-reactivity.
reservedBackground: l’infezione da Papillomavirus umano (HPV) è una delle infezioni sessualmente trasmesse più diffuse a livello globale. Ad oggi è riconosciuta come un rilevante fattore di rischio in entrambi i sessi per lo sviluppo di patologie ...
FAGGION, SOFIA
core
School nurses' perceptions of providing the HPV vaccine to adolescents in undervaccinated communities in Stockholm: A qualitative study. [PDF]
Avermark H, Ström M, Herzig van Wees S.
europepmc +1 more source
Evaluation of Adjuvant Administration of a Prophylactic HPV Vaccine in HPV-Positive Infertile Men: A Systematic Review. [PDF]
Banko A +5 more
europepmc +1 more source
Evaluating changes in women's attitudes towards cervical screening following a screening promotion campaign and a free vaccination program. CHERE Working Paper 2009/3 [PDF]
This study examines behavioural changes brought about by two interventions introduced to lower the incidence of cervical cancer in Australia. The first intervention is a media campaign promoting regular screening behaviour to women.
Marion Haas +3 more
core
The global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available.
Giuliano, Anna +11 more
core +1 more source
Navigating the divide - demographic and individual predictors of low HPV vaccine uptake in rural Uganda. [PDF]
Evarist MR, Kibonire RA.
europepmc +1 more source
HPV Vaccine Uptake, Hesitancy and Information Sources Among Young Adults: A Cross-Sectional Study of Korea and the US. [PDF]
Jo S, Xu D, Song H.
europepmc +1 more source
Addressing HPV vaccine hesitancy and misinformation in India through public health communication strategies. [PDF]
Jindal R +6 more
europepmc +1 more source
HPV vaccine: the key to a powerful shield against cancer. [PDF]
Kılavuz M +3 more
europepmc +1 more source
: Background Studies on the role of antibodies produced after infection with human papillomavirus 18 (HPV-18) and subsequent protection from HPV-18 infection have been conflicting, mainly due to inadequate sample size.
Wacholder, Sholom +32 more
core

